Takeda Pharmaceutical Co - ADR logo

TAK

Takeda Pharmaceutical Co - ADR

$13.9

Earnings Summary

Revenue
$972465Mn
Net Profits
$105014Mn
Net Profit Margins
10.8%
PE Ratio
13.26

Highlights

Revenue:

Takeda Pharmaceutical Co - ADR’s revenue jumped 2.41% since last year same period to $972465Mn in the Q2 2022. On a quarterly growth basis, Takeda Pharmaceutical Co - ADR has generated 11.36% jump in its revenue since last 3-months.

Net Profits:

Takeda Pharmaceutical Co - ADR’s net profit fell -23.73% since last year same period to $105014Mn in the Q2 2022. On a quarterly growth basis, Takeda Pharmaceutical Co - ADR has generated 1024.58% jump in its net profits since last 3-months.

Net Profit Margins:

Takeda Pharmaceutical Co - ADR’s net profit margin fell -25.52% since last year same period to 10.8% in the Q2 2022. On a quarterly growth basis, Takeda Pharmaceutical Co - ADR has generated 930.29% jump in its net profit margins since last 3-months.

PE Ratio:

Takeda Pharmaceutical Co - ADR’s price-to-earnings ratio after this Q2 2022 earnings stands at 13.26.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Takeda Pharmaceutical Co - ADR post its latest quarter earnings

EPS Estimate Current Quarter
0
EPS Estimate Current Year
0

Highlights

EPS Estimate Current Quarter:

Takeda Pharmaceutical Co - ADR’s earning per share (EPS) estimates for the current quarter stand at 0 - a -100% fall from last quarter’s estimates.

EPS Estimate Current Year:

Takeda Pharmaceutical Co - ADR’s earning per share (EPS) estimates for the current year stand at 0.

Key Ratios

Key ratios of the Takeda Pharmaceutical Co - ADR post its Q2 2022 earnings

Earning Per Share (EPS)
0.26
Return on Assets (ROA)
0.03
Return on Equity (ROE)
0.09
Dividend Per Share (DPS)
180

Highlights

Earning Per Share (EPS):

Takeda Pharmaceutical Co - ADR’s earning per share (EPS) fell -55.39% since last year same period to 0.26 in the Q2 2022. This indicates that the Takeda Pharmaceutical Co - ADR has generated -55.39% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Takeda Pharmaceutical Co - ADR’s return on assets (ROA) stands at 0.03.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Takeda Pharmaceutical Co - ADR’s return on equity (ROE) stands at 0.09.

Dividend Per Share (DPS):

Takeda Pharmaceutical Co - ADR declared 180 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2021-09-30
0
-0.05
-Inf%
2021-06-29
0
0.58
+Inf%
2021-07-30
0.87
0.58
-33.28%

Company Information

Organisation
Takeda Pharmaceutical Co - ADR
Headquarters
1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668
Employees
2021
Industry
Health Technology
CEO
Christophe Weber